NEUMEDICINES

Updated 64 days ago
  • ID: 7906427/130
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
We are a dedicated team of research and medical experts leading the clinical advancement of HemaMax as the ideal combination immunotherapeutic for the successful treatment of cancer.
  • 0
  • 0
Interest Score
1
HIT Score
0.00
CEO
Lena A. Basile
CMO
Vladimir Vainstein
Chairman
Lena A. Basile
President
Elliot P. Friedman
Domain
neumedicines.com
Actual
www.neumedicines.com
IP
50.87.147.41
Status
OK
Category
Company
0 comments Add a comment